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Abstract:  
The stability constant of Efavirenz drug with alkaline earth metal ions Mg(II), Ca(II)  and transition metal ions 
Fe(III), Cu(II) were investigate using pH metric titration technique in 20%(v/v) ethanol-water mixture at 27 °C 
temperature and at an ionic strength of 0.1M NaClO4.{Metal to ligand ratio = 1:5 & 1:1}The method of Calvin 
and Bjerrum as adopted by Irving and Rossotti has been employed to determine proton ligand (pKa) and metal-
ligand stability constants (log K) values. It is observed that alkaline earth metal & transition metal ion forms 1:1 
and 1:2 complexes. The order of stability constants for these metal complexes was as:                                                        
Fe3+ > Cu2+ > Mg2+ > Ca2+     
Keywords: Stability Constant, alkaline earth metal, transition metal, Efavirenz, pH metry. 
Introduction:  
Coordination compound containing one metal and one ligand is known as binary complex. Metal complexes 
with various ligand shows their contribution in the field of pollution control, medicine, industries, analytical 
chemistry, pharmacology, pathology biochemistry, metallurgy etc. The stability of metal complexes with 
medicinal drugs plays a major role in the biological and chemical activity. Most of the s-block and d-block 
elements form complexes. Mg (II) ions form complexes with several enzymes which are essential for energy 
release. Ca (II) is important in bone, teeth and blood clotting. It maintains the regular breathing of hearts, 
contraction of muscles. There are different kinds of ligand used for complexation. For the present investigation, 
we selected Efavirenz drug. Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used as 
a part of highly active anti-retroviral therapy (HAART) for the treatment of human immunodeficiency virus (HIV-
1). Both nucleoside and non‐nucleoside RTIs inhibit the same target. The reverse transcriptase enzyme 
transcribes viral RNA into DNA. Unlike nucleoside RTIs, which bind at the enzyme's active site, NNRTIs bind 
within a pocket, termed the NNRTI pocket. Efavirenz is not effective against HIV‐2, as the pocket of the HIV‐2 
reverse transcriptase has a different structure, which confers intrinsic resistance to the NNRTI class. It is never 
used alone and is always given in combination with other drugs. It is a white to slightly pink crystalline powder 
and it is soluble in various organic solvents but practically insoluble in water. It is chemically (4S)-6-chloro -
(cyclopropylethynyl)-1, 4-dihydro-4- (trifluoromethyl) - 2H-3, 1-benzoxazin-2-one.Efavirenz activity is mediated 
predominantly by non-competitive inhibition of HIV-1 RT. The toxicity of EFV is central nervous system (CNS) 
side-effects. The EFV-associated CNS side-effects typically resolve after two to four weeks. However, in some 
cases they can persist for months or not resolve at all. Thus, EFV should be avoided in patients with a history of 
psychiatric illness. 
After a review of literature survey and in continuation of our earlier work with complexation of medicinal drugs 
[1-10], we have carried out a solution study on the complexation of Efavirenz drug with with alkaline earth metal 
ions Mg2+, Ca2+ and transition metal ions Fe3+, Cu2+ using pH metrically in 20% (v/v) ethanol-water mixture at 
constant ionic strength of 0.1M NaClO4. 
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Materials and Methods:  
Efavirenz drug is soluble in 20% (v/v) ethanol-water mixture. NaOH, NaClO4, HClO4 and metal salts were of AR 
grade .The solutions used in the pH metric titration were prepared in double distilled water. The NaOH solution 
was standardized against oxalic acid solution (0.1M) and standard alkali solution was again used for 
standardization of HClO4. The metal salt solutions were also standardized using EDTA titration. All the 
measurements were made at 27 0C in 20% (V/V) ethanol-water mixture at constant ionic strength of 0.1M 
NaClO4.The thermostat model SL-131 was used to maintain the temperature constant. The pH measurement 
were made using a digital pH meter model Elico L1-120 in conjunction with a glass and reference calomel 
electrode (reading accuracy ± 0.01 pH units) the instrument was calibrated at pH 4.00 ,7.00 and 9.18 using the 
standard buffer solutions .  
For evaluating the protonation constant of the ligand and the formation constant of the complexes in 20 %( v/v) 
ethanol-water mixture with different metal ions we prepare the following sets of solutions. 
 (A) HClO4 (A) 
 (B) HClO4+ Efavirenz (A+ L) 
 (C) HClO4+ Efavirenz + Metal (A+ L+ M)  
The above mentioned sets prepared by keeping M : L ratio, the concentration of perchloric acid and sodium 
perchlorate (0.1M) were kept constant for all sets. The volume of every mixture was made up to 50 ml with 
double distilled water and the reaction solution were pH meterically titrated against the standard alkali at 
temperature 27 0C.  
Result and Discussion:  
Drug Efavirenz is non-nucleoside, reverse transcriptase inhibitor. The structural of drug shows one secondary 
amine group and one carbonyl group. The drug efavirenz gives only one pKa value. The protonation constant 
of drug obtained under experimental condition is 10.7206. This pKa value can be assigned to secondary amine 
group in the basic range. The proton ligand stability constant (pKa) of Efavirenz drug is determined by point 
wise calculation method as suggested by Irving and Rossoti.  Metal ligand stability constant (logK) transition 
metal ions with Efavirenz drug (ligand) were calculated by point wise and half integral method  of Calvin and 
Bjerrum as adopted by Irving and Rossotti has been employed. The order of stability constants for these metal 
complexes was as follows: 
Fe3+ > Cu2+ > Mg2+ > Ca2+    {Metal to ligand ratio=1:5}    and 
Fe3+ > Cu2+ > Mg2+ > Ca2+    {Metal to ligand ratio=1:1} 
Conclusion:  
In the present investigation, stability constants of alkaline earth metal and transition metal complexes with 
Efavirenz drug at 1:5 and 1:1 metal-ligand ratio were studied at 27 0C. It is found that stability constant of metal 
complexes when metal-ligand ratio 1:5 is greater than those of metal complexes when metal-ligand ratio is 1:1. 
This indicates that at higher concentration of ligand more stable complexes are formed. The stability constants 
of trivalent Fe show maximum stability whereas divalent Ca shows minimum stability.  
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Table 1. Proton-ligand and metal-ligand stability constant of Efavirenz drug in 20 % (v/v) ethanol-water 
medium (Metal to ligand ratio = 1:5) 
pKa logK Fe3+ Cu2+ Mg2+ Ca2+ 
10.7206 
logK1 11.2450 7.0282 3.7182 2.8045 
logK2 11.0221 6.8544 2.9312 2.4620 
log β 22.2671 13.8826 6.6494 5.2665 
Table 2. Proton-ligand and metal-ligand stability constant of Efavirenz drug in 20 % (v/v) ethanol-water 
medium (Metal to ligand ratio = 1:1) 
pKa logK Fe3+ Cu2+ Mg2+ Ca2+ 
10.7206 
logK1 12.0561 8.2540 3.9535 2.9732 
logK2 - - - - - - - - - - - - - - - - 
log β 12.0561 8.2540 3.9535 2.9732 
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Figure 1: Efavirenz (molecular formula is C14H9ClF3NO2 ) 
 
Figure 2: The pH metric titration curve for Cu (II)- Efavirenz 
0
2
4
6
8
10
12
0 1 2 3 4
pH
Volume of NaOH
To Chemistry Journal Vol 6 (2020) ISSN: 2581-7507                                 https://purkh.com/index.php/tochem 
72 
References: 
1. Ramesh L. Ware, Kishore N. Koinkar, Shailendrasingh V. Thakur, International Journal of Universal Science 
and Technology,3(1) Jan. 2018, 284-288. 
2. Ramesh Ware, Shoeb Peerzade and Shailendrasingh Thakur, International Journal of Universal Science 
and Technology, 3(1) Jan. 2018, 238-241 
3. Ramesh Ware and Shailendrasingh Thakur, International Journal of Universal print, 4(4) March 2018, 
254-260. 
4. Ramesh Ware, Shoeb Peerzade and Shailendrasingh Thakur, International Journal of Universal print, 4(5) 
March 2018, 274-278. 
5. Ramesh Ware and Shailendrasingh Thakur, Journal of Global Resources, July 2019, Volume 5(02), 265-
269 
6. Ramesh Ware, P.P.Ghumare, D.B.Jirekar, Shailendrasingh Thakur, RESEARCH JOURNEY International 
Multidisciplinary E-Research Journal, October 2019, Special Issue 199, 64-70 
7. Rajpal Jadhav, Ramesh Ware, Shailendrasingh Thakur, Journal of Research and Development, Jan.2020, 
Special Issue 02, Volume 10, 40-42. 
8. Shailendrasingh Thakur, S. A. Peerzade, A.J.Khan, R.L.Ware, International Multilingual Research Journal 
Printing Area (Special Issue), Dec. 2017,47-51 
9. Shailendrasingh Thakur and Ramesh Ware, Journal of Global Resources, July 2019, Volume 5(02), 224-
229 
10. Shailendrasingh Thakur, H.U.Joshi, M.A. Sakhare, Ramesh Ware, RESEARCH JOURNEY International 
Multidisciplinary E-Research Journal, October 2019, Special Issue 199, 71-77. 
